Sales y derivados de API
Las sales de los Ingredientes Farmacéuticos Activos (API) son compuestos formados por la reacción de un ácido con una base, resultando en un equilibrio iónico. Estas sales suelen mejorar la solubilidad y estabilidad de los APIs, facilitando su absorción en el cuerpo. Los derivados de API son variantes químicas de un principio activo que pueden tener propiedades mejoradas o modificadas para optimizar su eficacia terapéutica. Las sales de APIs se utilizan en la formulación de medicamentos orales, inyectables y tópicos. Además, los derivados de APIs pueden mejorar la farmacocinética de los fármacos, como la liberación controlada de activos.
En CymitQuimica contamos con sales y derivados de APIs con la pureza y calidad necesarias para investigación y desarrollo de formulaciones farmacéuticas.
Se han encontrado 79383 productos de "Sales y derivados de API"
Ordenar por
Pureza (%)
0
100
|
0
|
50
|
90
|
95
|
100
Iopromide
CAS:<p>Applications Nonionic, injectable radio-contrast medium. Diagnostic aid (radiopaque medium).<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Muetzel, W., et al.: Am.J. Neuroradiol., 4, 350 (1983), Dawson, P., et al.: Acta Radiol. Diagn., 25, 253 (1984),<br></p>Fórmula:C18H24I3N3O8Forma y color:NeatPeso molecular:791.11(1RS)-1-(3,5-Dihydroxyphenyl)2-[[(1RS)-2-(4-hydroxy-3-methylphenyl)-1-methylethyl]aminoethanol Hydrobromide
Producto controlado<p>Applications (1RS)-1-(3,5-Dihydroxyphenyl)2-[[(1RS)-2-(4-hydroxy-3-methylphenyl)-1-methylethyl]aminoethanol Hydrobromide is an impurity of Fenoterol Hydrobromide (F248850); a β2-adrenergic agonist. Also a bronchodilator and tocolytic.<br>References Schuster, B., et al. Arzneim.-Forsch., 19, 1905 (1969); Gerris, J., et al.: Eur. J. Clin. Pharmacol., 18, 443 (1980); Heel, R.C., et al.: Drugs, 15, 3 (1978)<br></p>Fórmula:C18H24BrNO4Forma y color:NeatPeso molecular:398.29Eltrombopag Olamine
CAS:<p>Stability Hygroscopic<br>Applications Eltrombopag is an agonist of the Thrombopoietin (Tpo) receptor, used as treatment for thrombocytopenia<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Bussel, J., et al.: New Eng. J. Med., 357, 2237 (2007), Marsilje, T., et al.: Bioorg. Med. Chem. Lett., 18, 5259 (2008), Alper, P., et al.: Bioorg. Med. Chem. Lett., 18, 5255 (2008)<br></p>Fórmula:C25H22N4O4·2C2H7NOForma y color:Dark RedPeso molecular:564.63(15R)-Bimatoprost Acid
CAS:Producto controlado<p>Applications (15R)-Bimatoprost Acid is an impurity of the antiglaucoma agent Bimatoprost (B386820). (15R)-Bimatoprost Acid is a metabolically stable analog of PGF2α (P838625) and is a potent agonist for the FP receptor.<br>References Balapure, A.K. et al.: Biochem. Pharmacol., 38, 2375 (1989); Hellberg, M.R. et al.: J. Ocular Pharmacol. Ther., 19, 97 (2003); Krishna, P.M. et al.: J. Pharm. res., 4, 2381 (2011); Resul, B., et al.: J. Med. Chem., 36, 243 (1993)<br></p>Fórmula:C23H32O5Forma y color:NeatPeso molecular:388.497O-Deshydroxyethyl Bosentan
CAS:<p>Impurity Bosentan USP Related Compound B<br>Applications O-Deshydroxyethyl Bosentan (Bosentan USP Related Compound B) is an impurity of Bosentan (B675900); a mixed endothelin receptor antagonist. Used as a vasodilator and antihypertensive.<br>References Clozel, M., et al.: J. Pharmacol. Exp. Ther., 270, 228 (1994); Gutsch, G., et al.: Cardiovasc. Drugs Ther., 10, 717 (1996); Weber, C., et al.: Clin Pharmacol. Ther., 60, 124 (1996); Krum, H., et al.: N. Engl. J. Med., 338, 784 (1998)<br></p>Fórmula:C25H25N5O5SForma y color:BeigePeso molecular:507.56Rivaroxaban-d4
CAS:Producto controladoFórmula:C19H14D4ClN3O5SForma y color:White To Off-WhitePeso molecular:439.91A77 1726 (E/Z) Mixture
CAS:Producto controlado<p>Impurity Leflunomide USP Related Compound B<br>Applications rac A77 1726 is the active metabolite of Leflunomide, a potent disease-modifying antirheumatic drug used in the treatment of rheumatoid arthritis. LEF-M interferes with dendritic cell function. The second Phase III study evaluating the efficacy of Genzyme’s teriflunomide therapy against relapsing forms of multiple sclerosis found the once-daily oral drug to be no less effective than injectable interferon beta 1a (Rebif®). Leflunomide USP Related Compound B.<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Kirsch, B.M., et al.: Arthritis Research and Therapy, 7, 3, R694, (2005)<br></p>Fórmula:C12H9F3N2O2Forma y color:NeatPeso molecular:270.21Pentoxifylline-d6
CAS:Producto controlado<p>Applications A labelled metabolite of Pentifylline. Methylxanthine derivative that improves blood flow by decreasing blood viscosity. Phosphodiesterase inhibitor. Inhibits the synthesis of tumor necrosis factor α (TNF-α).<br>References Ward, A., et al.: Drugs, 34, 50 (1987), Samlaska, C.P., et al.: J. Am. Acad. Dermatol., 30, 603 (1994), Poulakis, et al.: Respir. Med., 93, 52 (1999), Reuter, et al.: Am J. Physiol., 277, 854 (1999),<br></p>Fórmula:C132H6H12N4O3Forma y color:NeatPeso molecular:284.344-(2-Aminophenyl)-3-morpholinone
CAS:<p>Applications 4-(2-Aminophenyl)-3-morpholinone is a reagent used in the preparation of various Morpholine based pharmaceuticals.<br>References Mederski, W., et al.: Bioorg. Med. Chem. Lett., 14, 3763 (2004), Roehrig, S., et al.: J. Med. Chem., 48, 5900 (2005),<br></p>Fórmula:C10H12N2O2Forma y color:Off White SolidPeso molecular:192.214
![(1RS)-1-(3,5-Dihydroxyphenyl)2-[[(1RS)-2-(4-hydroxy-3-methylphenyl)-1-methylethyl]aminoethanol Hyd…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FTR%2Fthumb-webp%2FD453355.webp&w=3840&q=75)
